Your browser doesn't support javascript.
loading
A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma.
Bachy, Emmanuel; Le Gouill, Steven; Di Blasi, Roberta; Sesques, Pierre; Manson, Guillaume; Cartron, Guillaume; Beauvais, David; Roulin, Louise; Gros, François Xavier; Rubio, Marie Thérèse; Bories, Pierre; Bay, Jacques Olivier; Llorente, Cristina Castilla; Choquet, Sylvain; Casasnovas, René-Olivier; Mohty, Mohamad; Guidez, Stéphanie; Joris, Magalie; Loschi, Michaël; Carras, Sylvain; Abraham, Julie; Chauchet, Adrien; Drieu La Rochelle, Laurianne; Deau-Fischer, Bénédicte; Hermine, Olivier; Gastinne, Thomas; Tudesq, Jean Jacques; Gat, Elodie; Broussais, Florence; Thieblemont, Catherine; Houot, Roch; Morschhauser, Franck.
Affiliation
  • Bachy E; Hematology Department, Hospices Civils de Lyon, Pierre Bénite, Lyon, France. emmanuel.bachy@chu-lyon.fr.
  • Le Gouill S; International Center for Infectiology Research (CIRI), Inserm U1111, Lyon, France. emmanuel.bachy@chu-lyon.fr.
  • Di Blasi R; Hematology Department, Institut Curie, Paris, France.
  • Sesques P; Hematology Department, Hôpital Saint Louis, Paris, France.
  • Manson G; Hematology Department, Hospices Civils de Lyon, Pierre Bénite, Lyon, France.
  • Cartron G; Hematology Department, CHU de Rennes, Rennes, France.
  • Beauvais D; Hematology Department, CHU de Montpellier & UMR-CNRS, Montpellier, France.
  • Roulin L; Hematology Department, CHU de Lille, Lille, France.
  • Gros FX; Hematology Department, Hôpital Henri Mondor, Créteil, France.
  • Rubio MT; Hematology Department, CHU de Bordeaux, Bordeaux, France.
  • Bories P; Hematology Department, CHU de Nancy, Nancy, France.
  • Bay JO; Hematology Department, CHU de Toulouse, Toulouse, France.
  • Llorente CC; Hematology Department, CHU de Clermont Ferrand, Clermont-Ferrand, France.
  • Choquet S; Hematology Department, Gustave Roussy Cancer Campus, Villejuif, Paris, France.
  • Casasnovas RO; Hematology Department, Hôpital de la Pitié Salpêtrière & AP-HP Sorbonne Université, Paris, France.
  • Mohty M; Hematology Department, CHU de Dijon, Dijon, France.
  • Guidez S; Hematology Department, Hôpital Saint Antoine & Sorbonne University & Inserm UMRs 938, Paris, France.
  • Joris M; Hematology Department, CHU de Poitiers, Poitiers, France.
  • Loschi M; Hematology Department, CHU d'Amiens, Amiens, France.
  • Carras S; Hematology Department, CHU de Nice, Nice, France.
  • Abraham J; Hematology Department, CHU de Grenoble & University Grenoble-Alpes, Institute for Advanced Biosciences, La Tronche, France.
  • Chauchet A; Hematology Department, CHU de Limoges, Limoges, France.
  • Drieu La Rochelle L; Hematology Department, CHU de Besançon, Besançon, France.
  • Deau-Fischer B; Hematology Department, CHU de Tours, Tours, France.
  • Hermine O; Hematology Department, Hôpital Cochin, Paris, France.
  • Gastinne T; Hematology Department, Hôpital Necker, Paris, France.
  • Tudesq JJ; Hematology Department, CHU de Nantes, Nantes, France.
  • Gat E; Hematology Department, CHU de Montpellier & UMR-CNRS, Montpellier, France.
  • Broussais F; Biostatistics Department, LYSARC, Lyon, France.
  • Thieblemont C; Medical and Scientific Affairs Department, LYSARC, Lyon, France.
  • Houot R; Hematology Department, Hôpital Saint Louis, Paris, France.
  • Morschhauser F; Hematology Department, CHU de Rennes, Rennes, France.
Nat Med ; 28(10): 2145-2154, 2022 10.
Article in En | MEDLINE | ID: mdl-36138152
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biological Products / Immunotherapy, Adoptive / Lymphoma, Large B-Cell, Diffuse / Receptors, Chimeric Antigen Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2022 Document type: Article Affiliation country: Francia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biological Products / Immunotherapy, Adoptive / Lymphoma, Large B-Cell, Diffuse / Receptors, Chimeric Antigen Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2022 Document type: Article Affiliation country: Francia